Attached files

file filename
8-K - FORM 8-K - Kedem Pharmaceuticals Inc.kedem8-k.htm
 
February 6, 2013

Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549

 
Commissioners:
 
We have read the statements made by Kedem Pharmaceuticals Inc. (copy attached), which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 4.01 of Form 8-K, as part of the Form 8-K of Kedem Pharmaceuticals Inc. dated February 6, 2013. We agree with the statements concerning our Firm in such Form 8-K.
 
Yours very truly,
 
/s/ Leed Advisors Inc.

Leed Advisors Inc.
 
Chartered Accountants
 

Enclosures